PMS26 COST-EFFECTIVENESS OF SEQUENTIAL TREATMENT WITH ABALOPARATIDE FOLLOWED BY ALENDRONATE VS ALENDRONATE MONOTHERAPY FOR THE PREVENTION OF FRACTURES IN POSTMENOPAUSAL US WOMEN AT INCREASED RISK OF FRACTURE
May 1, 2019, 00:00
10.1016/j.jval.2019.04.1136
https://www.valueinhealthjournal.com/article/S1098-3015(19)31328-2/fulltext
Title :
PMS26 COST-EFFECTIVENESS OF SEQUENTIAL TREATMENT WITH ABALOPARATIDE FOLLOWED BY ALENDRONATE VS ALENDRONATE MONOTHERAPY FOR THE PREVENTION OF FRACTURES IN POSTMENOPAUSAL US WOMEN AT INCREASED RISK OF FRACTURE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)31328-2&doi=10.1016/j.jval.2019.04.1136
First page :
Section Title :
Open access? :
No
Section Order :
10660